US2018100141A1PendingUtilityA1

Multipotent progenitor cell derived from adipose tissue

44
Assignee: MATSUYAMA AKIFUMIPriority: Jun 14, 2007Filed: Nov 30, 2017Published: Apr 12, 2018
Est. expiryJun 14, 2027(~0.9 yrs left)· nominal 20-yr term from priority
A61P 9/00C12N 5/0667A61P 1/16
44
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed is a cell mass containing an adipose-tissue-derived multipotent progenitor cell. Also disclosed is a method for producing an adipose-tissue-derived multipotent progenitor cell from an adipose tissue, which comprises the steps of: (a) removing erythrocytes from an adipose-tissue-derived cell mass to produce a preadipose-tissue-derived multipotent progenitor cell mass; and (b) removing cells other than the adipose-tissue-derived multipotent progenitor cell from the preadipose-tissue-derived multipotent progenitor cell mass to produce the desired adipose-tissue-derived multipotent progenitor cell. Further disclosed is an adipose-tissue-derived multipotent progenitor cell produced by the method.

Claims

exact text as granted — not AI-modified
1 - 10 . (canceled) 
     
     
         11 . A method for obtaining a hepatic lobule-like cell cluster, cardiac myoblasts or bone tissue from an Islet-1 expressing adipose tissue-derived multipotent progenitor cell from an adipose tissue, comprising:
 (a) slicing and digesting adipose tissue to make an adipose cell extract of separated cells of adipose tissue-derived cell population;   (b) clarifying the separated cells from naturally occurring tissue and digestion products by centrifugation;   (c) selectively removing erythrocytes from the adipose tissue-derived cell population by the density method, then culturing;   (d) culturing in the presence of feeder cells and then washing the erythrocyte-free clarified adipose tissue-derived cell population;   (e) selectively removing vascular endothelial cells from the cultured and washed erythrocyte-free clarified adipose tissue-derived cell population by a chelator; thereby forming a tissue culture enriched in Islet-1 expressing adipose tissue-derived multipotent progenitor cell population with respect to erythrocytes and respect to vascular endothelial cells, and having a low fibroblast contamination comprising a 23 percent fibroblast cell contamination, and   (f) culturing said tissue culture enriched in Islet-1 expressing adipose tissue-derived multipotent progenitor cell population and obtaining a hepatic lobule-like cell cluster, cardiac myoblasts or bone tissue.   
     
     
         12 . The method according to  claim 11 , wherein the prepared culture lacks erythrocyte cells and vascular endothelial cells and contains feeder cells.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.